Log in

NASDAQ:NTUSNatus Medical Earnings Date, Estimates & History

$17.81
+0.17 (+0.96 %)
(As of 08/14/2020 04:00 PM ET)
Add
Compare
Today's Range
$17.40
Now: $17.81▼
$17.82
50-Day Range
$17.51
MA: $20.43▼
$22.47
52-Week Range
$17.37
Now: $17.81▼
$34.89
Volume256,494 shs
Average Volume274,125 shs
Market Capitalization$603.24 million
P/E RatioN/A
Dividend YieldN/A
Beta0.8

Earnings

Natus Medical (NASDAQ:NTUS) Earnings Information

Natus Medical last issued its quarterly earnings data on July 30th, 2020. The reported ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by $0.18. The firm had revenue of $84.78 million for the quarter, compared to analysts' expectations of $98.20 million. Natus Medical has generated $1.24 earnings per share over the last year. Natus Medical has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 22nd, 2020 based off prior year's report dates.

Natus Medical Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Natus Medical (NASDAQ:NTUS) Earnings Estimates

Current Year EPS Consensus Estimate: $0.11 EPS
Next Year EPS Consensus Estimate: $0.94 EPS

Natus Medical (NASDAQ NTUS) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
10/22/2020
(Estimated)		       
7/30/20206/30/2020$0.05($0.13)$98.20 million$84.78 millionTranscript
4/30/20203/31/2020$0.22$0.04$0.19$115.00 million$109.40 millionTranscript
2/6/202012/31/2019$0.47$0.46$0.82$130.00 million$131.76 millionTranscript
10/24/2019Q3$0.38$0.36$0.47$124.75 million$123.46 millionTranscript
7/25/2019Q2 2019$0.30$0.34$0.56$122.85 million$125.54 millionN/A
4/25/2019Q1 2019$0.06$0.09$0.92$113.30 million$114.76 millionN/A
2/13/2019Q4 2018$0.50$0.43$1.21$136.30 million$140.99 millionN/A
10/24/2018Q3 2018$0.42$0.40$0.97$132.92 million$130.64 millionN/A
7/25/2018Q2 2018$0.26$0.35$0.78$130.61 million$130.65 millionN/A
4/25/2018Q1 2018$0.24$0.24$0.58$126.39 million$128.61 millionN/A
2/7/2018Q4 2017$0.52$0.42$1.06$131.60 million$131.44 millionN/A
10/25/2017Q3 2017$0.38$0.40$1.06$122.20 million$122.64 millionN/A
7/26/2017Q2 2017$0.33$0.34$0.83$121.71 million$122.23 millionN/A
4/26/2017Q1 2017$0.33$0.30$0.59$122.48 million$124.66 millionN/A
2/1/2017Q4 2016$0.52$0.51$0.71$107.68 million$107.70 millionN/A
10/19/2016Q3 2016$0.36$0.39$0.38$90.25 million$90.91 millionN/A
7/20/2016Q2 2016$0.36$0.39$0.46$92.57 million$95.96 millionN/A
4/20/2016Q1 2016$0.30$0.34$0.42$87.52 million$87.33 millionN/A
1/27/2016Q4 2015$0.46$0.51$0.76$100.02 million$99.95 millionN/A
10/21/2015Q3 2015$0.38$0.39$0.45$93.49 million$94.58 millionN/A
7/22/2015Q2 2015$0.32$0.34$0.38$90.71 million$91.94 millionN/A
4/22/2015Q1 2015$0.29$0.31$0.36$89.01 million$89.40 millionN/A
1/28/2015Q4 2014$0.38$0.40$0.50$94.02 million$94.01 millionN/A
10/22/2014Q3 2014$0.31$0.33$0.42$87.74 million$89.88 millionN/A
7/23/2014Q2 2014$0.26$0.28$0.32$84.74 million$86.33 millionN/A
4/23/2014Q1 2014$0.23$0.26$0.33$85.18 million$85.62 millionN/A
1/29/2014Q4 2013$0.32$0.37$0.45$89.61 million$90.64 millionN/A
10/24/2013Q3 2013$0.19$0.30$0.40$80.35 million$85.39 millionN/A
8/1/2013Q2 2013$0.15$0.21$0.29$81.45 million$82.25 millionN/A
5/20/2013Q1 2013$0.11$0.15$0.19$84.47 million$85.83 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 8/15/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.